Organizing Committee

Xinghua Pan is a Professor at the Precision Regenerative Medicine Research Centre, Medical Science Division, Macau University of Science and Technology. He founded and directed the Guangdong Provincial Key Laboratory of Single Cell Technology and Application, and previously served as Professor and Chairman of the Department of Biochemistry and Molecular Biology at Southern Medical University, China. Earlier in his career, he spent over a decade as a Research Scientist and Principal Investigator at Yale University School of Medicine. He earned his MD and MS from Southern Medical University and his PhD from Fudan University under Dr. CC Tan. He completed two postdoctoral fellowships: one at the Chinese Academy of Medical Sciences & Peking Union Medical College with Dr. Min Wu, and another at Yale University with Dr. Sherman Weissman. Since the early 2000s, as a member of the international ENCODE consortium, he pioneered single-cell sequencing technologies, innovating methods for single-cell genomics, epigenomics, transcriptomics, and telomere analysis, and laid the groundwork for single-cell multi-omics. His research spans human development and diseases, with a focus on stemness and cancer. He has authored over 160 publications in journals such as PNAS, Nature Communications, Cell Discovery, and Advanced Science, with total citations exceeding 11,500. He holds 15 issued patents in the US and China. Dr. Pan serves as a reviewer and editorial board member for several prestigious journals including Nature series, and is the Associate Editor of Precision Clinical Medicine (Oxford University Press). He is also the founder and Chairman of the International Conference on Single-Cell and Spatial Omics (TICSSO).

Zheng Zhaomin, M.D., Ph.D., is a Professor and doctoral supervisor in the Department of Spine Surgery at the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. He serves as Vice Director of the Department of Spine Surgery and Director of the Guangdong Engineering Technology Research Center of Spinal Deformity. With more than 30 years of experience in spinal orthopaedics, his clinical and research interests include spinal deformity, minimally invasive spine surgery, and degenerative spinal disorders. Dr. Zheng has published extensively in leading international spine journals and holds leadership positions in several international spine societies, including serving as the 24th President of PASSMISS (2024), a Board Member of ISASS-Asia Pacific, and Associate Editor of the Asia Spine Journal.

Thomas J. Webster’s (H index: 136) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has formed over a dozen companies who have numerous FDA approved medical products currently improving human health in over 30,000 patients. He is also currently serving as a professor at Brown University, Saveetha University, Hebei University of Technology, University of the Basque Country, UFPI, and others.  Dr. Webster has numerous awards including: World Top 2% Scientist by Citations (PLOS); SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies.  Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,500 publications to his credit with over 75,000 citations. He was recently nominated for the Nobel Prize in Chemistry (2026). Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S.

Jock Findlay is a distinguished reproductive biologist and academic who has made significant contributions to reproductive health and fertility research. He joined the Prince Henry’s Institute (now the Hudson Institute of Medical Research) in 1979 and is a Fellow of the Academy of Health and Medical Sciences (FAHMS). Throughout his career, he has held several prestigious academic and leadership positions, including Adjunct Professor at Monash University (2009), Honorary Professor at the University of Melbourne (2009), Chair of the Advisory Board of the Robinson Research Institute at the University of Adelaide (2014–2016), and Past President of the Society for the Study of Reproduction (USA) (2014–2015). Professor Findlay has published more than 280 research papers and received numerous awards for his outstanding contributions. His research has primarily focused on understanding ovarian function, egg development, storage, and release, advancing knowledge of female fertility and the local actions of hormones. His work has played a key role in improving in vitro fertilization (IVF) techniques and enhancing the understanding of fertility and infertility. More recently, his research has expanded to investigating the mechanisms of chemoresistance and metastasis in ovarian cancer, contributing to the development of improved therapeutic approaches.

Rangsun Parnpai is a distinguished reproductive biologist and biotechnology researcher at the School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology (SUT), Thailand. He earned a Doctor of Agricultural Science (Animal Reproduction) from Kyoto University, Japan, following a Master of Science in Zoology from Kasetsart University and a Bachelor of Science in Biology from Burapha University. His research focuses on assisted reproductive technologies, including somatic cell cloning, in vitro embryo production, embryo transfer, cryopreservation of gametes and embryos, and stem cell biology for both animals and humans. Professor Parnpai has made significant contributions to animal reproduction, endangered species conservation, and regenerative medicine through his extensive research and publications. In recognition of his outstanding scientific achievements, he was named Thailand's National Outstanding Researcher in Agriculture and Biology in 2021 and, in 2026, received the prestigious High-Potential Research Group Grant from the National Research Council of Thailand (NRCT) and the National Science and Technology Development Agency (NSTDA) to advance innovative research on cloning and conservation of endangered species.

Jerard Seghatchian obtained dual degrees, one in radiation-induced free radical formation from the University of Paris and the other in biomedical pharmacology, from the University of London. His post-doctoral research includes radiation-induced polymerisation at the Centre National Research Scientific [CNRS, Orsay]. These academic qualifications were preparatory to a scientific career dedicated to illuminating complex mechanisms of hemostasis, thrombosis and hypercoagulability, collaborating, as invited visiting scientist, with several international leaders in haematological abnormalities and QA aspects. He was responsible for establishing some of the first standards/standardisation of blood component therapy while serving as the Principal Scientist of the newly created Components Developmental Laboratory at the NHSBT and in concert with the WHO-NIBSC, where he worked for three years as a part-time invited visiting scientist.

Reem Alzahrani is a molecular medicine researcher at Arabian Gulf University whose work centers on advancing women’s health through innovative cancer research and precision medicine. Her scientific contributions span breast cancer, ovarian cancer, HPV‑related disease prevention, and organoid‑based modeling of female malignancies. She specializes in developing patient‑derived tumor organoids to study tumor behavior, drug resistance, and individualized therapeutic strategies for women with breast and ovarian cancers. Dr. Alzahrani has authored peer‑reviewed publications on triple‑negative breast cancer, ovarian cancer stem cell niches, and public health research addressing HPV awareness among women. Her research integrates molecular biology, cancer stem cells, and advanced 3D culture systems to better understand diseases that disproportionately affect women and to improve early detection and treatment outcomes.

Liwu Fu is a Chinese cancer researcher and professor at the Sun Yat-sen University Cancer Center in Guangzhou, China. He serves as Director of the Department of Experimental Research and is internationally recognized for his work on cancer pharmacology, multidrug resistance, targeted therapies, and cancer immunotherapy. Dr. Fu earned his M.D. in 1987 and Ph.D. in 1996 from Sun Yat-sen University, followed by postdoctoral training at the Medical University of South Carolina. Over his career, he has published hundreds of scientific papers, secured multiple patents, and made significant contributions to the development of novel anticancer drugs and personalized cancer treatment strategies.

Yongliang Zhang is a Professor and Doctoral Supervisor at the College of Animal Science, South China Agricultural University, Guangzhou, China. He earned his Ph.D. in Biochemistry and Molecular Biology in 1999 and became a Doctoral Supervisor in the same field at Jilin University in 2005 before joining South China Agricultural University. He currently serves as Vice Chairman of the National Society of Animal Physiology and Biochemistry, the Society of Agricultural Biochemistry and Molecular Biology, and the Guangdong Provincial Animal Husbandry and Veterinary Society. In addition, he is the Deputy Director of the National Pig Breeding Industry Engineering Technology Research Center, Academic Leader, and Deputy Director of the Guangdong Provincial Key Laboratory of Agricultural Animal Genomics and Molecular Breeding. His research focuses on animal nutrition biochemistry, animal biotechnology, the development of functional feed additives, and feed biotechnology, with significant contributions to agricultural animal genomics and molecular breeding.

Jekaterina Erenpreisa is a Latvian biomedical scientist and cancer researcher affiliated with the Latvian Biomedical Research and Study Centre in Riga. Her research focuses on cancer cell biology, genome organization, epigenetics, polyploidy, and mechanisms of therapy resistance and tumor evolution. She has made significant contributions to understanding how cancer cells survive stress and adapt through genome reprogramming, and has authored numerous peer-reviewed scientific publications. Erenpreisa is also an active participant in international scientific conferences and collaborations, where she presents her work on genome regulation and cancer biology.

Hernane S. Barud is a Professor at Uniara, leading the BioPolMat and NUT3D laboratories. His international academic background includes visiting professorships in Canada, Portugal, Sweden, Argentina and France. His research advances biopolymer-based materials for medical, pharmaceutical, biophotonic and biological control applications. A prolific innovator, he has published over 200 articles and holds 25 patents, while serving as Editor-in-Chief of the IJAMB. As a visionary entrepreneur, he is the CEO and founder of the startups Biosmart and HB Biotech. His work effectively bridges the gap between high-level scientific research and industrial biotechnology solutions.

Román Pérez Antoñanzas is the Vice-Rector for Research, Innovation, and Knowledge Transfer at the Universitat Internacional de Catalunya (UIC Barcelona), as well as a Full Professor and senior researcher at the Bioengineering Institute Technology (BIT) within the same institution. He holds a Bachelor's Degree in Chemistry from the University of Barcelona (UB) and a PhD in Materials Science from the Universitat Politècnica de Catalunya (UPC)—including a doctoral research stay at Harvard University. Dr. Pérez boasts an extensive international career, having served as a faculty member and researcher at prestigious institutions such as the Institute of Tissue Regeneration Engineering at Dankook University in South Korea, University College Dublin, and Toronto Metropolitan University in Canada. His scientific expertise lies at the forefront of bioengineering, advanced biomaterials, and regenerative medicine. His primary lines of research focus on designing and developing functionalized synthetic and biological scaffolds for hard and soft tissue regeneration, as well as advancing hydrogels, bioinks, and 3D/coaxial bioprinting technologies aimed at biofabricating vascular structures, complex tissues, and bone regeneration matrices. Dr. Pérez has authored over 100 peer-reviewed scientific publications in high-impact international journals, holds 10 patents, and has led numerous competitive research projects at both national and international levels. Furthermore, his research output and scientific influence have consistently earned him a spot on Stanford University's prestigious Ranking of the World's Top 2% Scientists.

Begoña M. Bosch serves as the Director of the Bioengineering Department and is a Senior Researcher at the Bioengineering Institute Technology (BIT) at Universitat Internacional de Catalunya (UIC Barcelona). Holding a Degree in Pharmacy and a PhD in Health Sciences and Bioengineering, her multidisciplinary research expertise spans tissue engineering, cell therapy with a specialized focus on stem cell-based tissue regeneration, functional biomaterials, and advanced cosmetic technology. Throughout her academic career, Dr. Bosch has made significant contributions to the fields of regenerative medicine and biomaterials science, authoring peer-reviewed scientific publications in international journals. In recognition of her impactful research and innovative scientific achievements, she has received prestigious grants and awards, including distinguished recognition from the Spanish Society of Cosmetic Chemists (SEQC) for her research in novel cosmetic developments and biopolymer technologies. At BIT, Dr. Bosch leads cutting-edge research initiatives focused on bridging advanced material science with stem cell therapies, guiding multidisciplinary teams to develop bio-inspired scaffolds and cell-delivery platforms tailored for tissue repair and regenerative applications. Her active work integrates custom bio-interfaces, and natural hydrogels to overcome major bottlenecks in tissue engineering, advancing functional cell expansion strategies from translational research toward potential therapeutic and technological applications.

Sunjay Kaushal, PhD, MD, is a highly experienced pediatric cardiovascular surgeon at Sunrise Children’s Heart Surgery Center, affiliated with Sunrise Children’s Hospital in Nevada. He specializes in treating children and newborns with congenital heart conditions. His expertise includes neonatal cardiac surgery, complex biventricular repair, aortic and mitral valve repair, and Ebstein Anomaly repair. Dr. Kaushal is board certified in surgery, thoracic surgery, and congenital cardiac surgery. He earned his MD from Johns Hopkins School of Medicine and completed pediatric cardiac surgery fellowships at Great Ormond Street Hospital and University of Michigan. He has also participated in international pediatric heart surgery missions in India.

Linpeng Fan is the Founder and Group Leader of the BioSymphony Research Group at The University of Melbourne and an ARC DECRA Fellow in Biomedical Engineering. His research investigates how structure–function coupling across material and biological scales can be engineered to regulate cellular behavior, coordinate tissue regeneration, and reconstruct physiologically relevant tissue function. He translates these principles into biomimetic tissue and organ models, regenerative technologies, and responsive biointerfaces for intelligent and adaptive biomedical systems. Through this work, he has developed spatially organized microenvironments that provide instructive cues for cellular organization and tissue repair, including a targeted regenerative platform that has progressed from fundamental discovery to preclinical validation. Building on these advances, his group is developing biointerfaces that integrate microenvironmental regulation, personalized fabrication, therapeutic function, and biointegrated sensing to support regenerative and translational medicine. His work has been published in leading journals including Nature Communications, ACS Nano, and Nano Letters.

Abdulrahim Shamayleh serves as Associate Professor and Head of the Department of Industrial Engineering in the College of Engineering at American University of Sharjah. He earned his PhD in Industrial, Systems and Operations Engineering from Arizona State University in 2010, an MS in Industrial and Systems Engineering from San Jose State University in 2004, and a BS in Industrial Engineering from the University of Jordan in 2001. His professional career includes appointments as Assistant Professor at King Fahd University of Petroleum and Minerals from 2010 to 2014, followed by his transition to Assistant Professor at American University of Sharjah in 2014, where he was promoted to Associate Professor in 2021. In his current role as department head, he oversees academic programs and faculty in industrial engineering.Shamayleh’s research focuses on operations research applications in healthcare, scheduling, supply chain management, facilities planning and design, project management, and healthcare management. He is a Certified Supply Chain Professional (CSCP) and certified instructor through the Association for Supply Chain Management. His teaching areas encompass supply chain management, facilities planning and design, project management, production and operations analysis, engineering economics, and cost accounting. Shamayleh maintains active memberships in the Institute of Industrial and Systems Engineers, the Association for Supply Chain Management, and the Institute for Operations Research and the Management Sciences. He received the CEN Teaching Award from the College of Engineering at American University of Sharjah in 2021. His scholarly contributions include numerous peer-reviewed publications in these domains, with work cited extensively in academic literature.

Nissim Benvenisty is the Herbert Cohn Chair in Cancer Research and the Director of The Azrieli Center for Stem Cells and Genetic Research at the Hebrew University. He earned his M.D. and Ph.D. degrees from the Hebrew University, and conducted postdoctoral studies at Harvard University. Prof. Benvenisty’s research projects focus on stem cell biology, tissue engineering, human genetics, and cancer research. He published over 200 original and review papers on human pluripotent stem cells, and is a member of the steering committee of the International Stem Cell Initiative (ISCI). Prof. Benvenisty presents the issue of human pluripotent stem cells in many international conferences, and gave testimonies before the US Senate and the European Union. He was awarded several prizes among them the Foulkes Prize (London), the Hestrin Prize, the Teva Prize, the Kaye Prize, the Milken Prize, the Azrieli Center Award (Canada), the ACTO Award (Japan), the Katzir Prize and the Rappaport Prize.

William Cho is a Biomedical Scientist in Queen Elizabeth Hospital. His main research interests have been focusing on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He is a Chartered Scientist granted by the Science Council (UK), a Registered Chinese Medicine Practitioner (HK), Guest Professor of a number of Universities and a Fellow Member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences. Dr Cho has published over 200 peer-reviewed papers (Lancet Oncology, Clinical Cancer Research, Clinical Chemistry, Annuals of Oncology, etc) covering cancer biomarkers, proteomics, microRNAs, Chinese medicine and plenty of books including "MicroRNAs in cancer translational research", "An omics perspective on cancer research", "Supportive cancer care with Chinese medicine", etc.

Jiuzhou Song, Ph.D., is a Professor in the Department of Animal and Avian Sciences at the University of Maryland. He is a researcher in statistical genetics, genomics, epigenetics, and systems biology, with a particular focus on understanding how genetic and epigenetic mechanisms influence complex traits, disease resistance, and animal health. His research examines interactions between livestock genomes and environmental factors, including infection and nutrition, with the goal of identifying biomarkers and improving livestock performance.

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School working on development of vascular compliance graft and one year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 687 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He supervised 121 PhD students, all successfully completed. He is currently director of NRMC centre (co-founder of NanoRegMed Ltd, Nanoloom Ltd and Liberum Health Ltd) working on the commercialisation of his research.  During his career, he has led and managed many innovative projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. He won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society.

G. Taru Sharma is a molecular reproductive biologist, her major research area is stem cell therapeutics in livestock and pets, did her doctorate in 1989 from Indian Veterinary Research Institute, Izatnagar, Animal Physiology a Major discipline, Animal Biochemistry and Animal Reproduction as Minor disciplines, Worked at LSU, Baton Rouge, USA on somatic cell cloning using bovine IVF embryos. Before joining NIAB, served as a Principal Scientist and Head Physiology and Climatology Division, Director Centre for Advanced Faculty Training and Chairperson, faculty of Veterinary Physiology, at IVRI. She has a research and academic experience at the CIRG, Centre for Biotechnology, NDDB, Mumbai, mentored by Prof. KKG Menon at NDDB and Dr. Lalji Singh at CCMB, Hyderabad for buffalo embryo sexing. Research Scientist at Bio Med., a vaccine producing cell, the QC Unit. She is Fellow NASI, NAAS, mentored M.V.Sc and Ph.D scholars, Member of the Inter academia panel for women in STEMM,the founder president of Animal Physiologists Association.